Skip to main content
Indian Journal of Otolaryngology and Head & Neck Surgery logoLink to Indian Journal of Otolaryngology and Head & Neck Surgery
. 2025 Mar 28;77(4):1969–1980. doi: 10.1007/s12070-025-05446-z

Potential Cost Savings in Medicare Part D for Otolaryngologic Medications

Om B Tripathi 1,✉, Aman M Patel 1, Hassaam S Choudhry 1, David W Wassef 1, Paul T Cowan 1, Richard Chan Woo Park 1,2, Andrey Filimonov 1
PMCID: PMC11985713  PMID: 40226259

Abstract

Our study analyzes potential savings and losses for Medicare Part D using Mark Cuban Cost Plus Drug Company (MCCPDC) as an alternative medication procurement method for the 75 most commonly prescribed medications by otolaryngologists in 2022. Monthly standard MCCPDC costs and imputed Medicare Part D monthly costs for each prescription medication were compared. Our results indicated heterogenous efficiency of sourcing medications through MCCPDC due to some potential cost savings but other substantial losses. 45.3% of the top 75 otolaryngologic prescription medications sorted by total spending were not available on MCCPDC, indicating the need for more affordable access to expensive medications. Additionally, antibiotics consistently displayed potential losses through MCCPDC procurement, suggesting Medicare’s ability to achieve discount pricing for particular drug categories. Hence, providers should consider utilizing direct-to-consumer (DTC) models on a case-by-case basis, and future cost-saving investigations including additional DTC models should be conducted.

Keywords: Mark Cuban Cost Plus Drug Company, Medicare Part D, Cost Savings, Otolaryngology, Drug Distribution

Introduction

The Medicare Part D program is designed to help beneficiaries pay for prescription medications and control out-of-pocket expenses [1]. Due to intermediaries involved between manufacturers and consumers, prescription medications are often subject to significant price markups within distribution models despite having generic counterparts. This burden is heightened by restrictions on Medicare’s ability to negotiate drug prices and set preferred generic manufacturers, which increases monthly premiums and out-of-pocket (OOP) costs for Medicare beneficiaries [2]. In response, MCCPDC was created in January 2022 as a direct-to-consumer (DTC) company. Previous studies have shown Medicare overspending in comparison with DTC approaches, such as the Mark Cuban Cost Plus Drug Company (MCCPDC), that could save a minimum of $1.29 billion, $661.8 million, $64.5 million on urologic, oncologic, and ophthalmologic medications, respectively [2, 3, 4].

Methods

This study analyzes availability and potential savings if Medicare Part D sourced medications directly from MCCPDC for the 75 medications most commonly prescribed by otolaryngologists in 2022. We utilized data from the Center for Medicare and Medicaid Services (CMS) files and the MCCPDC website. Although numerous DTC models exist, we selected MCCPDC due to its relative newness to the market, making it attractive to investigate from a specialty-specific perspective, and its fixed cost-plus-pricing approach. Medications on MCCPDC are sold at a fixed 15% markup, $5 pharmacy service fee, and $5 shipping fee. Each form of the medication was reported individually, and quantity was held at the smallest count for each available form, either 1- or 30-count. Monthly standard cost was taken as an average of all strength variations. All brand name alternatives found on MCCPDC were included to provide consistency and account for off-label usage. Although every medication form was included within the tables, medications with multiple forms were excluded from our top 10 savings and losses categories in our results section to prevent inaccurate estimations due to unclear delineation of forms in the Medicare Part D database. Shipping costs set at $5 per order on the MCCPDC website were excluded from the final monthly value as their inclusion could overestimate total costs for customers ordering > 1 medication. To account for inflation, 2022 Medicare prices were adjusted to estimate 2024 prices using the National Average Drug Acquisition Cost data.

Results

Of the 75 medications prescribed by otolaryngologists with the most claims, 23 (30.7%) were not available on the MCCPDC website (Table 1). The 10 medications associated with the highest savings on MCCPDP were Azelastine HCL - Optivar ($10,580,178.71), Azelastine HCL - Astelin ($9,925,397.15), Fluticasone Propionate – Flonase ($5,692,152.58), Mometasone Furoate – Nasonex ($1,213,744.20), Tobramycin/Dexamethasone ($706,543.95), Azelastine/Fluticasone ($703,066.54), Cefdinir ($561,403.80), Pilocarpine HCL – Salagen ($514,365.97), Esomeprazole Magnesium ($458,072.68), Doxycycline Hyclate – Lymepak ($437,875.68). If the ten listed medications were purchased from MCCPDC, estimated annual costs would be 47.7% of total expenditure by Medicare Part D, totaling $30,334,728.58 in potential monthly savings.

Table 1.

Savings profile for the top 75 otolaryngology medications by total 2022 prescription fills

Medication Dose (Strength: Volume) Form Total 2022 Medicare Part D Spending Total 2022 30-Day Prescriptions in Medicare Part D Imputed Monthly Costs for Medicare Part D ($) Monthly Standard MCCPDC ($) Potential Savings ($)
Fluticasone Propionate (Flonase) 50mcg:16mL Nasal Spray 17,543,104.21 1,136,158.20 15.45 10.44 5,692,152.58
Fluticasone Propionate (Cutivate) 0.005%:15 g Tube of Ointment 17,543,104.21 1,136,158.20 15.45 10.87 5,203,604.56
Fluticasone Propionate (Cutivate) 0.05%:60mL Bottle of Lotion 17,543,104.21 1,136,158.20 15.45 128.65 (128,613,108.24)
Fluticasone Propionate (Cutivate) 0.05%:60 g Cream 17,543,104.21 1,136,158.20 15.45 20.18 (5,374,028.29)
Fluticasone Propionate (Cutivate) 0.005%:60gm Ointment 17,543,104.21 1,136,158.20 15.45 29.71 (16,201,615.93)
Azelastine Hcl (Astelin) 0.1%:30mL Nasal Spray 15,635,459.03 545,651.30 28.66 10.47 9,925,397.15
Azelastine Hcl (Optivar) 0.05%:6mL Solution 15,635,459.03 545,651.30 28.66 9.27 10,580,178.71
Ipratropium Bromide 0.02%:30 × 2.5mL Vial of Solution 16,796,060.76 520,094.30 32.3 14.58 9,216,071.00
Ipratropium Bromide 0.06%:15mL Nasal Spray 16,796,060.76 520,094.30 32.3 20.53 6,121,509.91
Ipratropium Bromide 0.03%:30mL Nasal Spray 16,796,060.76 520,094.30 32.3 20.53 6,121,509.91
Omeprazole 20 mg Delayed Release Capsule 3,455,167.27 482,381.70 7.17 6.35 395,552.99
Famotidine 10 mg, 20 mg, 40 mg Tablet 3,264,958.02 444,454.80 7.35 6.20 511,123.02
Famotidine 40 mg / 5mL:50mL Suspension 50mL 3,264,958.02 444,454.80 7.35 25.70 (8,155,745.58)
Montelukast Sodium 10 mg Tablet 3,222,638.37 432,946.80 7.45 6.20 541,183.50
Montelukast Sodium 4 mg Packet 3,222,638.37 432,946.80 7.45 34.10 (11,538,032.22)
Montelukast Sodium 4 mg, 5 mg Packet 3,222,638.37 432,946.80 7.45 6.80 281,415.42
Prednisone 5 mg:21 Tablets, 10 mg:48 Tablets Tablet Therapy Pack 767,596.02 154,360.00 4.98 13.85 (1,369,173.20)
Prednisone 1 mg, 2.5 mg, 5 mg, 10 mg, 20 mg, 50 mg Tablet 767,596.02 154,360.00 4.98 7.60 (404,423.20)
Prednisone 5 mg/5mL:120mL Bottle of Solution 767,596.02 154,360.00 4.98 85.10 (12,367,323.20)
Mupirocin 2%:22 g Ointment 1,387,342.74 130,041.40 10.67 7.25 444,741.59
Mupirocin 2%:15 g,30 g Cream 1,387,342.74 130,041.40 10.67 19.54 (1,153,467.22)
Amoxicillin/Potassium Clav 1000-62.5 mg Extended Release Tablet 1,906,399.91 123,787.60 15.41 206.00 (23,592,678.68)
Pantoprazole Sodium - - 1,617,809.41 208,988.60 7.75 - -
Methylprednisolone 4 mg:21 pack Blister Pack of 21 Tablets 918,420.00 98,303.80 9.35 7.74 158,269.12
Methylprednisolone 4 mg, 8 mg, 16 mg, 32 mg Tablet 918,420.00 98,303.80 9.35 42.28 (3,237,144.13)
Ofloxacin (Floxin) 300 mg, 400 mg Tablet 4,777,483.44 95,881.70 49.83 380.30 (31,686,025.40)
Ofloxacin (Ocuflox) 0.3%:5mL Ophthalmic Solution − 5mL 4,777,483.44 95,881.70 49.83 14.11 3,424,894.32
Ofloxacin (Ocuflox) 0.3%:10mL Ophthalmic Solution − 10mL 4,777,483.44 95,881.70 49.83 15.30 3,310,795.10
Mometasone Furoate (Nasonex) 50mcg:17 g Suspension 3,467,521.34 72,203.70 48.03 31.22 1,213,744.20
Mometasone Furoate (Elocon) 0.10%:45 g Cream 3,467,521.34 72,203.70 48.03 14.15 2,446,261.36
Mometasone Furoate (Elocon) 0.10%:45 g Ointment 3,467,521.34 72,203.70 48.03 18.70 2,117,734.52
Varicella-Zoster Ge/As01b/Pf - - 16,061,601.00 83,030.00 193.45 - -
Hydrocodone/Acetaminophen - - 609,375.58 73,699.00 8.27 - -
Levocetirizine Dihydrochloride 5 mg Tablet 1,208,263.83 127,773.90 9.46 6.50 378,210.74
Levocetirizine Dihydrochloride 2.5 mg/5mL:148mL Solution 1,208,263.83 127,773.90 9.46 23.74 (1,824,611.29)
Levothyroxine Sodium 25mcg, 75mcg, 100mcg, 137mcg, 150mcg Tablet 1,549,498.17 144,863.50 10.7 10.18 75,329.02
Azithromycin 250 mg, 500 mg, 600 mg Tablet 402,942.35 49,306.20 8.18 16.80 (425,019.44)
Ciprofloxacin Hcl/Dexameth - - 8,082,874.32 49,249.10 164.13 - -
Cephalexin (Keflex) 250 mg, 500 mg, 750 mg Capsule 340,962.72 45,353.40 7.52 86.20 (3,568,405.51)
Cephalexin (Keftab) 250 mg Tablet 340,962.72 45,353.40 7.52 35.60 (1,273,523.47)
Fluocinolone Acetonide Oil - - 3,135,136.19 53,615.80 58.48 - -
Doxycycline Hyclate (Doryx) 50 mg, 75 mg, 100 mg, 150 mg, 200 mg Tablet Delayed Release 886,088.40 43,098.00 20.56 54.82 (1,476,537.48)
Doxycycline Hyclate (TargaDOX) 50 mg Tablet 886,088.40 43,098.00 20.56 166.40 (6,285,412.32)
Doxycycline Hyclate (Acticlate) 75 mg, 150 mg Tablet 886,088.40 43,098.00 20.56 17.60 127,570.08
Doxycycline Hyclate (Lymepak) 100 mg Tablet 886,088.40 43,098.00 20.56 10.40 437,875.68
Doxycycline Hyclate (Vibramycin) 20 mg Tablet 886,088.40 43,098.00 20.56 8.90 502,522.68
Doxycycline Hyclate (Vibramycin) 50 mg, 100 mg Capsule 886,088.40 43,098.00 20.56 9.50 476,663.88
Cefdinir 300 mg Capsule 1,091,097.58 42,402.10 25.74 12.50 561,403.80
Neomycin/Polymyxin B/Hydrocort 3.5 mg/mL 10,000 unit/mL 1%:10mL Suspension 2,425,096.92 38,527.60 62.95 41.40 830,269.78
Neomycin/Polymyxin B/Hydrocort 3.5-10000-1:7.5mL Solution Dropper 2,425,096.92 38,527.60 62.95 154.25 (3,517,569.88)
Neomycin/Polymyxin B/Hydrocort 1%:10mL Solution 2,425,096.92 38,527.60 62.95 56.11 263,528.78
Ciprofloxacin Hcl - - 363,024.80 30,158.50 12.04 - -
Triamterene/Hydrochlorothiazid 37.5-25 mg Capsule 300,703.93 59,900.70 5.03 6.80 (106,024.24)
Amoxicillin 250 mg, 500 mg Capsule 136,005.80 24,617.10 5.53 7.10 (38,648.85)
Amoxicillin 500 mg, 875 mg Tablet 136,005.80 24,617.10 5.53 7.85 (57,111.67)
Amoxicillin 125 mg, 250 mg Tablet Chewable 136,005.80 24,617.10 5.53 13.85 (204,814.27)
Triamcinolone Acetonide (Oralone) 0.1%:5 g Paste 489,660.91 24,861.60 19.7 20.78 (26,850.53)
Triamcinolone Acetonide (Trianex) 0.05%:430 g Jar of Ointment 489,660.91 24,861.60 19.7 86.75 (1,666,970.28)
Triamcinolone Acetonide (Aristocort A) 0.1%:15 g,454 g,80 g Ointment 489,660.91 24,861.60 19.7 12.22 185,964.77
Triamcinolone Acetonide (Aristocort A) 0.025%:15 g,454 g,80 g Cream 489,660.91 24,861.60 19.7 13.33 158,368.39
Triamcinolone Acetonide (Triderm) 0.1%:15 g,30 g,454 g,80 g, 0.5%:15 g Cream 489,660.91 24,861.60 19.7 10.22 235,687.97
Triamcinolone Acetonide (Kenalog) 0.025%:15 g Tube of Ointment 489,660.91 24,861.60 19.7 7.75 297,096.12
Triamcinolone Acetonide (Kenalog) 0.147 mg/gm:100 g Bottle of Solution Spray 489,660.91 24,861.60 19.7 147.32 (3,172,837.39)
Triamcinolone Acetonide (Kenalog) 0.1%:60mL, 0.025%:60mL Lotion 489,660.91 24,861.60 19.7 21.69 (49,474.58)
Gabapentin - - 338,506.64 30,735.70 11.02 - -
Sulfamethoxazole/Trimethoprim (Bactrim) 400-80 mg, 800-160 mg Tablet 147,245.02 23,256.50 6.34 6.35 (232.56)
Sulfamethoxazole/Trimethoprim (Sulfatrim) 200-40 mg/5mL:473mL Bottle of Suspension 147,245.02 23,256.50 6.34 28.11 (506,294.01)
Cefuroxime Axetil 250 mg, 500 mg Tablet 681,189.53 22,606.10 30.14 12.20 405,553.43
Meclizine Hcl (Travel-Ease) 25 mg Tablet 201,888.98 22,085.40 9.15 5.90 71,777.55
Meclizine Hcl (Antivert) 12.5 mg Tablet 201,888.98 22,085.40 9.15 6.50 58,526.31
Clindamycin Hcl 75 mg, 150 mg, 300 mg Capsule 238,867.59 19,131.80 12.49 10.60 36,159.10
Clindamycin Hcl 75 mg/5mL:100mL Solution 238,867.59 19,131.80 12.49 14.78 (43,811.82)
Clindamycin Hcl 2%:40 g Tube of Cream 238,867.59 19,131.80 12.49 58.36 (877,575.67)
Diazepam - - 71,304.41 18,538.90 3.85 - -
Oxycodone Hcl - - 238,487.95 17,106.00 13.95 - -
Nystatin (Nystop) 100,000 unit/g:60 g Powder 416,308.04 16,329.70 25.5 16.56 145,987.52
Nystatin (Nystex) 100,000 unit/g:30 g Ointment 416,308.04 16,329.70 25.5 9.67 258,499.15
Nystatin (Mycostatin) 100,000 unit/mL:60mL Bottle of Suspension 416,308.04 16,329.70 25.5 9.23 265,684.22
Nystatin (Mycostatin) 100,000 unit/g:15 g Cream 416,308.04 16,329.70 25.5 7.78 289,362.28
Nystatin (Mycostatin) 500,000 unit Tablet 416,308.04 16,329.70 25.5 12.20 217,185.01
Levofloxacin 250 mg, 500 mg, 750 mg Tablet 158,952.10 14,889.30 10.68 12.40 (25,609.60)
Levofloxacin 25 mg/mL:200mL Bottle of Solution 158,952.10 14,889.30 10.68 403.91 (5,854,919.44)
Oxycodone Hcl/Acetaminophen - - 120,436.18 14,465.00 8.33 - -
Ondansetron (Zofran ODT) 4 mg ODT Tablet 161,994.74 14,311.80 11.32 10.70 8,873.32
Ondansetron (Zofran) 4 mg, 8 mg Tablet 161,994.74 14,311.80 11.32 7.40 56,102.26
Ondansetron (Zofran) 4 mg/5mL:50mL Bottle of Solution 161,994.74 14,311.80 11.32 14.41 (44,223.46)
Fluconazole 50 mg, 100 mg, 150 mg, 200 mg Tablet 255,304.72 14,474.20 17.64 11.60 87,424.17
Doxycycline Monohydrate (Monodox) 50 mg, 100 mg Capsule 247,693.17 11,896.40 20.83 7.85 154,415.27
Doxycycline Monohydrate (Adoxa Pak 1/150) 150 mg Tablet 247,693.17 11,896.40 20.83 13.70 84,821.33
Doxycycline Monohydrate (Vibramycin Monohydrate) 25 mg/5mL:60mL Bottle of Suspension 247,693.17 11,896.40 20.83 17.31 41,875.33
Doxycycline Monohydrate (Adoxa) 50 mg, 75 mg, 100 mg Tablet 247,693.17 11,896.40 20.83 11.10 115,751.97
Doxycycline Monohydrate (Adoxa) 150 mg Capsule 247,693.17 11,896.40 20.83 43.40 (268,501.75)
Clotrimazole/Betamethasone Dip 1%-0.05% Cream 281,205.10 11,929.60 23.58 12.27 134,923.78
Clotrimazole/Betamethasone Dip 1%-0.05% Bottle of Lotion 281,205.10 11,929.60 23.58 60.38 (439,009.28)
Epinephrine - - 3,053,846.03 12,327.80 247.73 - -
Diphth, pertuss(Acell), tet Vac - - 684,358.12 10,911.00 62.73 - -
Amitriptyline Hcl 10 mg, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg Tablet 123,441.39 15,336.20 8.05 8.00 766.81
Nortriptyline Hcl 10 mg, 25 mg, 50 mg, 75 mg Capsule 158,999.31 16,519.10 9.63 7.18 40,471.80
Tobramycin/Dexamethasone 0.3 − 0.1% Suspension Dropper 980,458.62 10,021.90 97.84 27.34 706,543.95
Clotrimazole (Mycelex) 1%:30mL Bottle of Solution 442,987.91 10,478.40 42.28 16.16 273,695.81
Clotrimazole (Mycelex) 10 mg Lozenge 442,987.91 10,478.40 42.28 14.90 286,898.59
Clotrimazole (Lotrimin AF) 1%:28.4 g Cream 442,987.91 10,478.40 42.28 6.50 374,917.15
Clotrimazole (Gyne-Lotrimin) 1%:45 g Vaginal Cream 442,987.91 10,478.40 42.28 8.40 355,008.19
Tramadol Hcl - - 47,465.15 9,975.50 4.76 - -
Chlorhexidine Gluconate 0.12%:473mL Bottle of Solution 61,006.63 10,010.10 6.1 7.11 (10,110.20)
Esomeprazole Magnesium 20 mg Delayed Release Tablet 665,796.35 16,232.20 41.02 12.80 458,072.68
Azelastine/Fluticasone 137-50mcg/Act:23 g Nasal Spray 1,426,466.32 10,293.80 138.58 70.28 703,066.54
Pilocarpine Hcl (Salagen) 5 mg, 7.5 mg Tablet 663,132.73 12,508.90 53.02 11.90 514,365.97
Pilocarpine Hcl (Isoto Carpine) 4%:15mL, 2%:15mL, 1%:15mL Bottle of Solution 663,132.73 12,508.90 53.02 31.65 267,315.19
Dexamethasone Sodium Phosphate - - 409,779.69 8,374.40 48.94 - -
Prednisolone Acetate - - 459,479.42 8,714.30 52.73 - -
Alprazolam - - 52,225.20 7,709.90 6.78 - -
Hydrochlorothiazide 12.5 mg, 25 mg, 50 mg Tablet 33,529.08 15,378.40 2.19 6.10 (60,129.54)
Hydrochlorothiazide 12.5 mg Capsule 33,529.08 15,378.40 2.19 6.20 (61,667.38)
Dexamethasone (Dexpak) 1.5 mg:21 Tablets 6-day Dose Pack 151,627.11 8,253.90 18.38 144.76 (1,043,127.88)
Dexamethasone (Dexpak) 1.5 mg:51 Tablets 13-day Dose Pack 151,627.11 8,253.90 18.38 339.21 (2,648,098.74)
Dexamethasone (Dexpak) 1.5 mg:35 Tablets 10-day Dose Pack 151,627.11 8,253.90 18.38 237.97 (1,812,473.90)
Dexamethasone (Decadron) 0.5 mg, 0.75 mg, 1 mg, 1.5 mg, 2 mg, 4 mg, 6 mg Tablet 151,627.11 8,253.90 18.38 13.49 40,361.57
Dexamethasone (Decadron) 0.5 mg/5mL:237mL Bottle of Elixir 151,627.11 8,253.90 18.38 16.77 13,288.78
Dexamethasone (Decadron) 0.5 mg/5mL:500mL Bottle of Solution 151,627.11 8,253.90 18.38 20.64 (18,653.81)
Dexamethasone (Decadron) 0.1%:5mL Solution Dropper 151,627.11 8,253.90 18.38 43.60 (208,163.36)
Acetaminophen With Codeine - - 40,507.19 6,505.00 6.23 - -
Clonazepam - - 57,538.52 7,901.30 7.29 - -
Dupilumab - - 22,264,185.90 6,408.00 3474.44 - -
Promethazine Hcl 12.5 mg, 25 mg, 50 mg Tablet 33,658.25 6,492.20 5.19 6.35 (7,530.95)
Promethazine Hcl 12.5 mg:12 Suppositories Pack of Suppositories 33,658.25 6,492.20 5.19 26.73 (139,841.99)
Promethazine Hcl 6.25 mg/5mL:473mL Bottle of Syrup 33,658.25 6,492.20 5.19 20.92 (102,122.31)
Valacyclovir Hcl - - 373,840.61 7,823.30 47.79 - -
Albuterol Sulfate (AccuNeb) 0.63 mg/3mL: Box of 25 Vials Nebulization Solution 266,843.60 6,806.70 39.21 25.57 92,843.39
Albuterol Sulfate (AccuNeb) 1.25 mg/3mL:75mL Pack of Inhalation Suspension Vials 266,843.60 6,806.70 39.21 17.54 147,501.19
Albuterol Sulfate (Proventil) 2.5 mg/0.5mL: Box of 30 Vials Nebulization Solution 266,843.60 6,806.70 39.21 20.10 130,076.04
Albuterol Sulfate (Proventil) 2 mg/5mL:473mL Bottle of Syrup 266,843.60 6,806.70 39.21 17.80 145,731.45
Albuterol Sulfate (Proventil) 90mcg:6.7 g Inhaler 266,843.60 6,806.70 39.21 17.30 149,134.80
Albuterol Sulfate (Proventil) 0.083%:90mL Pack of Nebulization Solution Vials 266,843.60 6,806.70 39.21 12.76 180,037.22
Albuterol Sulfate (Proventil) 2 mg, 4 mg Tablet 266,843.60 6,806.70 39.21 10.10 198,143.04
Lorazepam - - 23,369.88 6,092.10 3.84 - -
Ondansetron Hcl - - 45,175.02 5,281.80 8.56 - -
Ibuprofen 200 mg, 400 mg, 600 mg, 800 mg Tablet 38,191.71 5,351.30 7.14 6.05 5,832.92
Ibuprofen 100 mg/5mL:118mL Bottle of Suspension 38,191.71 5,351.30 7.14 7.89 (4,013.48)
Meloxicam (Vivlodex) 7.5 mg, 15 mg Tablet 25,364.24 5,992.70 4.24 5.75 (9,048.98)
Meloxicam (Mobic) 5 mg, 10 mg Capsule 25,364.24 5,992.70 4.24 273.95 (1,616,291.12)
Clarithromycin 250 mg, 500 mg Tablet 159,620.34 4,905.50 32.54 14.60 88,004.67
Sodium Chloride Irrig Solution - - 111,916.75 5,070.90 22.08 - -
Lansoprazole 15 mg, 30 mg Delayed Release Capsule 213,869.34 8,186.50 26.13 9.05 139,825.42
Olopatadine Hcl (Patanase) 0.6%:30.5 g Solution Spray 460,689.54 6,193.80 74.38 19.60 339,296.36
Olopatadine Hcl (Pataday) 0.1%;5mL Ophthalmic Solution 460,689.54 6,193.80 74.38 10.43 396,093.51
Betamethasone Valerate (Luxiq) 0.12%:50 g Can of Foam 100,706.69 4,006.80 25.14 27.30 (8,654.69)
Betamethasone Valerate (Betatrex) 0.1%:15 g Tube of Ointment 100,706.69 4,006.80 25.14 13.61 46,198.40
Betamethasone Valerate (Beta-Val) 0.1%:15 g Tube of Cream 100,706.69 4,006.80 25.14 8.02 68,596.42
Betamethasone Valerate (Beta-Val) 0.1%:45 g Cream 100,706.69 4,006.80 25.14 16.24 35,660.52
Betamethasone Valerate (Beta-Val) 0.1%:60mL Bottle of Lotion 100,706.69 4,006.80 25.14 27.40 (9,055.37)
Acetic Acid 2%:15mL Bottle of Solution 88,135.92 4,059.70 21.71 17.61 16,644.77
Acyclovir 200 mg Capsule 108,662.82 5,551.90 19.58 6.80 70,953.28
Acyclovir 5%:15 g,30 g Ointment 108,662.82 5,551.90 19.58 8.22 63,069.58
Acyclovir 200 mg/5mL:473mL Suspension 473mL 108,662.82 5,551.90 19.58 78.82 (328,894.56)
Acyclovir 400 mg, 800 mg Tablet 108,662.82 5,551.90 19.58 8.00 64,291.00
Acyclovir 5%:5 g Tube of Cream 108,662.82 5,551.90 19.58 70.81 (284,423.84)

The 10 medications associated with the highest losses were Ofloxacin – Floxin ($31,686,025.40), Amoxicillin/Potassium Clavulanate ($23,592,678.68), Doxycycline Hyclate – TargaDOX ($6,285,412.32), Cephalexin – Keflex ($3,568,405.51), Triamcinolone Acetonide – Trianex ($1,666,970.28), Meloxicam – Mobic ($1,616,291.12), Doxycycline Hyclate – Doryx ($1,476,537.48), Cephalexin – Keftab ($1,273,523.47), Sulfamethoxazole/Trimethoprim – Sulfatrim ($506,294.01), Azithromycin ($425,019.44). If MCCPDC was used by Medicare Part D as the source of prescription medications, estimated monthly government overspending on these listed medications would total $72,097,157.71.

When sorting prescriptions by highest monthly expenditure, 34 (45.3%) were not available on the MCCPDC website (Table 2). 27 (36%) new medications were included and compared to Table 1. The 10 medications associated with the highest savings on MCCPDP were Azelastine HCL – Optivar ($10,580,178.71), Azelastine HCL – Astelin ($9,925,397.15), Fluticasone Propionate – Flonase ($5,692,152.58), Mometasone Furoate – Nasonex ($1,213,744.20), Dexlansoprazole ($777,480.61), Tobramycin/Dexamethasone ($706,543.95), Azelastine/Fluticasone ($703,066.54), Budesonide – Pulmicort Respules ($655,191.43), Cefdinir ($561,403.80), Pilocarpine HCL – Salagen ($514,365.97). If the ten listed medications were purchased from MCCPDC, estimated annual costs would be 46.8% of total expenditure by Medicare Part D, totaling $31,329,524.94 in potential monthly savings.

Table 2.

Savings profile for the top 75 otolaryngology medications by total 2022 medicare part D spending

Medication Dose (Strength: Volume) Form Total 2022 Medicare Part D Spending Total 2022 30-Day Prescriptions in Medicare Part D Imputed Monthly Costs for Medicare Part D ($) Monthly Standard MCCPDC ($) Potential Savings ($)
Dupilumab - - 22,264,185.90 6,408.00 3474.44 - -
Fluticasone Propionate (Flonase) 50mcg:16mL Nasal Spray 17,543,104.21 1,136,158.20 15.45 10.44 5,692,152.58
Fluticasone Propionate (Cutivate) 0.005%:15 g Tube of Ointment 17,543,104.21 1,136,158.20 15.45 10.87 5,203,604.56
Fluticasone Propionate (Cutivate) 0.05%:60mL Bottle of Lotion 17,543,104.21 1,136,158.20 15.45 128.65 (128,613,108.24)
Fluticasone Propionate (Cutivate) 0.05%:60 g Cream 17,543,104.21 1,136,158.20 15.45 20.18 (5,374,028.29)
Fluticasone Propionate (Cutivate) 0.005%:60gm Ointment 17,543,104.21 1,136,158.20 15.45 29.71 (16,201,615.93)
Ipratropium Bromide 0.02%:30 × 2.5mL Vial of Solution 16,796,060.76 520,094.30 32.3 14.58 9,216,071.00
Ipratropium Bromide 0.06%:15mL Nasal Spray 16,796,060.76 520,094.30 32.3 20.53 6,121,509.91
Ipratropium Bromide 0.03%:30mL Nasal Spray 16,796,060.76 520,094.30 32.3 20.53 6,121,509.91
Varicella-Zoster Ge/As01b/Pf - - 16,061,601.00 83,030.00 193.45 - -
Azelastine Hcl (Astelin) 0.1%:30mL Nasal Spray 15,635,459.03 545,651.30 28.66 10.47 9,925,397.15
Azelastine Hcl (Optivar) 0.05%:6mL Solution 15,635,459.03 545,651.30 28.66 9.27 10,580,178.71
Ciprofloxacin Hcl/Dexameth - - 8,082,874.32 49,249.10 164.13 - -
Ofloxacin (Floxin) 300 mg, 400 mg Tablet 4,777,483.44 95,881.70 49.83 380.30 (31,686,025.40)
Ofloxacin (Ocuflox) 0.3%:5mL Ophthalmic Solution − 5mL 4,777,483.44 95,881.70 49.83 14.11 3,424,894.32
Ofloxacin (Ocuflox) 0.3%:10mL Ophthalmic Solution − 10mL 4,777,483.44 95,881.70 49.83 15.30 3,310,795.10
Mometasone Furoate (Nasonex) 50mcg:17 g Suspension 3,467,521.34 72,203.70 48.03 31.22 1,213,744.20
Mometasone Furoate (Elocon) 0.10%:45 g Cream 3,467,521.34 72,203.70 48.03 14.15 2,446,261.36
Mometasone Furoate (Elocon) 0.10%:45 g Ointment 3,467,521.34 72,203.70 48.03 18.70 2,117,734.52
Omeprazole 20 mg Delayed Release Capsule 3,455,167.27 482,381.70 7.17 6.35 395,552.99
Famotidine 10 mg, 20 mg, 40 mg Tablet 3,264,958.02 444,454.80 7.35 6.20 511,123.02
Famotidine 40 mg / 5mL:50mL Suspension 50mL 3,264,958.02 444,454.80 7.35 25.70 (8,155,745.58)
Montelukast Sodium 10 mg Tablet 3,222,638.37 432,946.80 7.45 6.20 541,183.50
Montelukast Sodium 4 mg Packet 3,222,638.37 432,946.80 7.45 34.10 (11,538,032.22)
Montelukast Sodium 4 mg, 5 mg Packet 3,222,638.37 432,946.80 7.45 6.80 281,415.42
Fluocinolone Acetonide Oil - - 3,135,136.19 53,615.80 58.48 - -
Epinephrine - - 3,053,846.03 12,327.80 247.73 - -
Neomycin/Polymyxin B/Hydrocort 3.5 mg/mL 10,000 unit/mL 1%:10mL Suspension 2,425,096.92 38,527.60 62.95 41.40 830,269.78
Neomycin/Polymyxin B/Hydrocort 3.5-10000-1:7.5mL Solution Dropper 2,425,096.92 38,527.60 62.95 154.25 (3,517,569.88)
Neomycin/Polymyxin B/Hydrocort 1%:10mL Solution 2,425,096.92 38,527.60 62.95 56.11 263,528.78
Amoxicillin/Potassium Clav 1000-62.5 mg Extended Release Tablet 1,906,399.91 123,787.60 15.41 206.00 (23,592,678.68)
Dexlansoprazole 30 mg, 60 mg Capsule Delayed Release 1,618,125.15 5,265.70 307.3 159.65 777,480.61
Pantoprazole Sodium - - 1,617,809.41 208,988.60 7.75 - -
Levothyroxine Sodium 25mcg, 75mcg, 100mcg, 137mcg, 150mcg Tablet 1,549,498.17 144,863.50 10.7 10.18 75,329.02
Sodium, calcium, mag, pot Oxybate - - 1,532,278.16 100.00 15322.79 - -
Azelastine/Fluticasone 137-50mcg/Act:23 g Nasal Spray 1,426,466.32 10,293.80 138.58 70.28 703,066.54
Sodium Oxybate - - 1,403,344.46 73.00 19223.9 - -
Mupirocin 2%:22 g Ointment 1,387,342.74 130,041.40 10.67 7.25 444,741.59
Mupirocin 2%:15 g,30 g Cream 1,387,342.74 130,041.40 10.67 19.54 (1,153,467.22)
Levocetirizine Dihydrochloride 5 mg Tablet 1,208,263.83 127,773.90 9.46 6.50 378,210.74
Levocetirizine Dihydrochloride 2.5 mg/5mL:148mL Solution 1,208,263.83 127,773.90 9.46 23.74 (1,824,611.29)
Mepolizumab - - 1,182,545.35 310.40 3809.75 - -
Omalizumab - - 1,126,986.27 392.80 2869.11 - -
Cefdinir 300 mg Capsule 1,091,097.58 42,402.10 25.74 12.50 561,403.80
Tobramycin/Dexamethasone 0.3 − 0.1% Suspension Dropper 980,458.62 10,021.90 97.84 27.34 706,543.95
Methylprednisolone 4 mg:21 pack Blister Pack of 21 Tablets 918,420.00 98,303.80 9.35 7.74 158,269.12
Methylprednisolone 4 mg, 8 mg, 16 mg, 32 mg Tablet 918,420.00 98,303.80 9.35 42.28 (3,237,144.13)
Doxycycline Hyclate (Doryx) 50 mg, 75 mg, 100 mg, 150 mg, 200 mg Tablet Delayed Release 886,088.40 43,098.00 20.56 54.82 (1,476,537.48)
Doxycycline Hyclate (TargaDOX) 50 mg Tablet 886,088.40 43,098.00 20.56 166.40 (6,285,412.32)
Doxycycline Hyclate (Acticlate) 75 mg, 150 mg Tablet 886,088.40 43,098.00 20.56 17.60 127,570.08
Doxycycline Hyclate (Lymepak) 100 mg Tablet 886,088.40 43,098.00 20.56 10.40 437,875.68
Doxycycline Hyclate (Vibramycin) 20 mg Tablet 886,088.40 43,098.00 20.56 8.90 502,522.68
Doxycycline Hyclate (Vibramycin) 50 mg, 100 mg Capsule 886,088.40 43,098.00 20.56 9.50 476,663.88
Budesonide/Formoterol Fumarate 80-4.5mcg/Act:10.2 g Inhaler, 160-4.5mcg/Act:10.2 g Inhaler Aerosol Inhaler 866,512.60 2,360.00 367.17 194.50 407,501.20
Budesonide (Pulmicort) 1 mg/2mL:30 Ampules Carton of Ampules 834,711.05 5,457.20 152.96 168.82 (86,551.19)
Budesonide (Uceris) 2 mg:2 Cans Pack of Foam Canisters 834,711.05 5,457.20 152.96 623.35 (2,567,012.31)
Budesonide (Uceris) 9 mg Tablet Extended Release 834,711.05 5,457.20 152.96 416.00 (1,435,461.89)
Budesonide (Pulmicort Respules) 0.25 mg/2mL:60mL (30 × 2mL), 0.5 mg/2mL:60mL (30 × 2mL) Box of 30 Vials 834,711.05 5,457.20 152.96 32.90 655,191.43
Fluticasone/Vilanterol - - 767,675.45 1,973.00 389.1 - -
Prednisone 5 mg:21 Tablets, 10 mg:48 Tablets Tablet Therapy Pack 767,596.02 154,360.00 4.98 13.85 (1,369,173.20)
Prednisone 1 mg, 2.5 mg, 5 mg, 10 mg, 20 mg, 50 mg Tablet 767,596.02 154,360.00 4.98 7.60 (404,423.20)
Prednisone 5 mg/5mL:120mL Bottle of Solution 767,596.02 154,360.00 4.98 85.10 (12,367,323.20)
Fluticasone/Umeclidin/Vilanter - - 758,154.26 1,189.00 637.65 - -
Diphth, pertuss(Acell), tet Vac - - 684,358.12 10,911.00 62.73 - -
Chenodiol - - 682,914.96 12.00 56909.58 - -
Cefuroxime Axetil 250 mg, 500 mg Tablet 681,189.53 22,606.10 30.14 12.20 405,553.43
Esomeprazole Magnesium 20 mg Delayed Release Tablet 665,796.35 16,232.20 41.02 12.80 458,072.68
Pilocarpine Hcl (Salagen) 5 mg, 7.5 mg Tablet 663,132.73 12,508.90 53.02 11.90 514,365.97
Pilocarpine Hcl (Isoto Carpine) 4%:15mL, 2%:15mL, 1%:15mL Bottle of Solution 663,132.73 12,508.90 53.02 31.65 267,315.19
Adalimumab - - 647,633.98 93.00 6963.81 - -
Lanadelumab-Flyo - - 636,114.44 13.00 48931.88 - -
Hydrocodone/Acetaminophen - - 609,375.58 73,699.00 8.27 - -
Fluticasone Propion/Salmeterol - - 566,504.03 1,804.00 314.03 - -
Immun Glob G(Igg)/Pro/Iga 0–50 - - 507,687.42 48.00 10576.83 - -
Triamcinolone Acetonide (Oralone) 0.1%:5 g Paste 489,660.91 24,861.60 19.7 20.78 (26,850.53)
Triamcinolone Acetonide (Trianex) 0.05%:430 g Jar of Ointment 489,660.91 24,861.60 19.7 86.75 (1,666,970.28)
Triamcinolone Acetonide (Aristocort A) 0.1%:15 g,454 g,80 g Ointment 489,660.91 24,861.60 19.7 12.22 185,964.77
Triamcinolone Acetonide (Aristocort A) 0.025%:15 g,454 g,80 g Cream 489,660.91 24,861.60 19.7 13.33 158,368.39
Triamcinolone Acetonide (Triderm) 0.1%:15 g,30 g,454 g,80 g, 0.5%:15 g Cream 489,660.91 24,861.60 19.7 10.22 235,687.97
Triamcinolone Acetonide (Kenalog) 0.025%:15 g Tube of Ointment 489,660.91 24,861.60 19.7 7.75 297,096.12
Triamcinolone Acetonide (Kenalog) 0.147 mg/gm:100 g Bottle of Solution Spray 489,660.91 24,861.60 19.7 147.32 (3,172,837.39)
Triamcinolone Acetonide (Kenalog) 0.1%:60mL, 0.025%:60mL Lotion 489,660.91 24,861.60 19.7 21.69 (49,474.58)
Olopatadine Hcl (Patanase) 0.6%:30.5 g Solution Spray 460,689.54 6,193.80 74.38 19.60 339,296.36
Olopatadine Hcl (Pataday) 0.1%;5mL Ophthalmic Solution 460,689.54 6,193.80 74.38 10.43 396,093.51
Prednisolone Acetate - - 459,479.42 8,714.30 52.73 - -
Clotrimazole (Mycelex) 1%:30mL Bottle of Solution 442,987.91 10,478.40 42.28 16.16 273,695.81
Clotrimazole (Mycelex) 10 mg Lozenge 442,987.91 10,478.40 42.28 14.90 286,898.59
Clotrimazole (Lotrimin AF) 1%:28.4 g Cream 442,987.91 10,478.40 42.28 6.50 374,917.15
Clotrimazole (Gyne-Lotrimin) 1%:45 g Vaginal Cream 442,987.91 10,478.40 42.28 8.40 355,008.19
Nystatin (Nystop) 100,000 unit/g:60 g Powder 416,308.04 16,329.70 25.5 16.56 145,987.52
Nystatin (Nystex) 100,000 unit/g:30 g Ointment 416,308.04 16,329.70 25.5 9.67 258,499.15
Nystatin (Mycostatin) 100,000 unit/mL:60mL Bottle of Suspension 416,308.04 16,329.70 25.5 9.23 265,684.22
Nystatin (Mycostatin) 100,000 unit/g:15 g Cream 416,308.04 16,329.70 25.5 7.78 289,362.28
Nystatin (Mycostatin) 500,000 unit Tablet 416,308.04 16,329.70 25.5 12.20 217,185.01
Dexamethasone Sodium Phosphate - - 409,779.69 8,374.40 48.94 - -
Azithromycin 250 mg, 500 mg, 600 mg Tablet 402,942.35 49,306.20 8.18 16.80 (425,019.44)
Apremilast - - 381,589.98 84.00 4542.74 - -
Valacyclovir Hcl - - 373,840.61 7,823.30 47.79 - -
Ciprofloxacin Hcl - - 363,024.80 30,158.50 12.04 - -
Cevimeline Hcl 30 mg:100 Capsules Bottle of Capsules 355,916.92 2,725.80 130.58 53.30 210,649.82
Hydrocortisone/Acetic Acid 1–2%:10mL Solution Dropper 346,689.08 3,321.50 104.38 96.75 25,343.05
Cephalexin (Keflex) 250 mg, 500 mg, 750 mg Capsule 340,962.72 45,353.40 7.52 86.20 (3,568,405.51)
Cephalexin (Keftab) 250 mg Tablet 340,962.72 45,353.40 7.52 35.60 (1,273,523.47)
Gabapentin - - 338,506.64 30,735.70 11.02 - -
Tasimelteon 20 mg Capsule 317,452.86 12.00 26454.41 13610.00 154,132.92
Vismodegib - - 315,412.41 24.00 13142.19 - -
Triamterene/Hydrochlorothiazid 37.5-25 mg Capsule 300,703.93 59,900.70 5.03 6.80 (106,024.24)
Guselkumab - - 293,086.16 40.60 7218.88 - -
Ustekinumab - - 291,717.05 36.40 8014.21 - -
Clotrimazole/Betamethasone Dip 1%-0.05% Cream 281,205.10 11,929.60 23.58 12.27 134,923.78
Clotrimazole/Betamethasone Dip 1%-0.05% Bottle of Lotion 281,205.10 11,929.60 23.58 60.38 (439,009.28)
Albuterol Sulfate (AccuNeb) 0.63 mg/3mL: Box of 25 Vials Nebulization Solution 266,843.60 6,806.70 39.21 25.57 92,843.39
Albuterol Sulfate (AccuNeb) 1.25 mg/3mL:75mL Pack of Inhalation Suspension Vials 266,843.60 6,806.70 39.21 17.54 147,501.19
Albuterol Sulfate (Proventil) 2.5 mg/0.5mL: Box of 30 Vials Nebulization Solution 266,843.60 6,806.70 39.21 20.10 130,076.04
Albuterol Sulfate (Proventil) 2 mg/5mL:473mL Bottle of Syrup 266,843.60 6,806.70 39.21 17.80 145,731.45
Albuterol Sulfate (Proventil) 90mcg:6.7 g Inhaler 266,843.60 6,806.70 39.21 17.30 149,134.80
Albuterol Sulfate (Proventil) 0.083%:90mL Pack of Nebulization Solution Vials 266,843.60 6,806.70 39.21 12.76 180,037.22
Albuterol Sulfate (Proventil) 2 mg, 4 mg Tablet 266,843.60 6,806.70 39.21 10.10 198,143.04
Semaglutide - - 262,510.98 291.10 901.79 - -
Cyclosporine (Restasis) 0.05%:12mL (30 × 0.4mL) Box of 30 Vials (Emulsion) 260,764.59 786.30 331.64 69.40 206,199.31
Cyclosporine (Restasis) 0.05%:24mL (60 × 0.4mL) Box of 60 Vials (Emulsion) 260,764.59 786.30 331.64 130.35 158,274.33
Cyclosporine (Sandimmune) 25 mg:30 Capsules, 100 mg:30 Capsules Bottle of Capsules 260,764.59 786.30 331.64 226.05 83,025.42
Buprenorphine Hcl/Naloxone Hcl - - 256,580.20 770.80 332.88 - -
Fluconazole 50 mg, 100 mg, 150 mg, 200 mg Tablet 255,304.72 14,474.20 17.64 11.60 87,424.17
Beclomethasone Dipropionate - - 252,690.75 931.00 271.42 - -
Doxycycline Monohydrate (Monodox) 50 mg, 100 mg Capsule 247,693.17 11,896.40 20.83 7.85 154,415.27
Doxycycline Monohydrate (Adoxa Pak 1/150) 150 mg Tablet 247,693.17 11,896.40 20.83 13.70 84,821.33
Doxycycline Monohydrate (Vibramycin Monohydrate) 25 mg/5mL:60mL Bottle of Suspension 247,693.17 11,896.40 20.83 17.31 41,875.33
Doxycycline Monohydrate (Adoxa) 50 mg, 75 mg, 100 mg Tablet 247,693.17 11,896.40 20.83 11.10 115,751.97
Doxycycline Monohydrate (Adoxa) 150 mg Capsule 247,693.17 11,896.40 20.83 43.40 (268,501.75)
Clindamycin Hcl 75 mg, 150 mg, 300 mg Capsule 238,867.59 19,131.80 12.49 10.60 36,159.10
Clindamycin Hcl 75 mg/5mL:100mL Solution 238,867.59 19,131.80 12.49 14.78 (43,811.82)
Clindamycin Hcl 2%:40 g Tube of Cream 238,867.59 19,131.80 12.49 58.36 (877,575.67)
Oxycodone Hcl - - 238,487.95 17,106.00 13.95 - -
Secukinumab - - 232,680.52 32.00 7271.27 - -
Apixaban - - 219,968.32 560.30 392.6 - -

Using the same parameters, the 10 medications associated with the highest losses were Ofloxacin – Floxin ($31,686,025.40), Amoxicillin/Potassium Clavulanate ($23,592,678.68), Doxycycline Hyclate – TargaDOX ($6,285,412.32), Cephalexin – Keflex ($3,568,405.51), Triamcinolone Acetonide – Trianex ($1,666,970.28), Doxycycline Hyclate – Doryx ($1,476,537.48), Cephalexin – Keftab ($1,273,523.47), Azithromycin ($425,019.44), Triamterene/Hydrochlorothiazide ($106,024.24), Budesonide – Pulmicort ($86,551.19). If MCCPDC was used by Medicare Part D as the direct source of prescription medications, estimated government overspending on these listed medications would total $70,167,148.01 monthly.

Discussion

Exploring alternatives to CMS traditional routes is important for reducing federal spending and beneficiary premiums [5]. This is particularly impactful for the field of otolaryngology, as previous research has already shown high markups for certain otolaryngologic services [6]. The contrasting results of potential savings and losses, heavily dependent on the medication, indicate both significant opportunities for cost savings and notable risks of overspending under blanket MCCPDC procurement. This aligns with previous medication-saving evaluations for direct-to-consumer models that imply the efficiency of MCCPDC to be heterogeneous, suggesting that a one-size-fits-all strategy may not be optimal [7].

Of the top 75 otolaryngologic prescription medications sorted by total spending, a substantial 45.3% were not listed on the MCCPDC platform. This is a trend not only for otolaryngologic medications but across a wide range of generics, as merely 26% of expensive generic drugs were available on the MCCPDC website in May 2023, underscoring the pressing need for more affordable access to expensive medications that may not be readily found in alternative drug distribution models [7]. Moreover, a large number of antibiotics were seen within our top 10 potential loss categories, suggesting that Medicare can achieve discounts for specific medication categories within drug distribution models. This is consistent with discussions on Medicare leveraging various factors, such as rebates and pharmacy-related price concessions, to save on prescription drug spending [8]. As a result, providers should carefully consider options before urging patients to order prescription workflows through DTC sources without consulting their Medicare Part D plan in order to re-emphasize our findings of a mix of savings and losses among otolaryngologic medications through theoretical MCCPDC procurement.

Limitations in the present analysis consist of Medicare Part D data not differentiating forms and doses, deeming it difficult to delineate particular medications on MCCPDC. Pricing calculations in the present cost-analysis are subject to fluctuations due to dynamic time and market conditions along with impending and future legislations pertinent to drug pricing and transparency. Only MCCPDC was selected to examine, but other DTC sources have also shown potential savings for Medicare Part D beneficiaries through hybrid approaches, which warrants additional investigation on alternative DTC sources for otolaryngologic medications and determination of the most cost-effective model [2]. Although warehouse clubs (e.g., Costco) have also shown savings on common generic drugs, these clubs are restricted to customers with active membership accounts and have limited medication scope, which hinder the generalization of results to the broader patient population [9]. Moreover, warehouse clubs deem cost-saving analysis complicated as prices are not readily available online for non-members, and hence we excluded them from our study.

Conclusion

Our study conducted a cost analysis utilizing Mark Cuban Cost Plus Drug Company (MCCPDC) for the top 75 most prescribed and expended on otolaryngologic medications. Our results indicate that sourcing select medications from MCCPDC could yield substantial cost savings but also carries risks of overspending for Medicare Part D. We suggest a tailored approach, rather than a uniform adoption of direct-to-consumer models to maximize savings while maintaining comprehensive access.

Author Contributions

Om B. Tripathi: design, analysis, interpretation, manuscript writing; Aman M. Patel: conception, design, analysis, interpretation, manuscript writing; Hassaam S. Choudhry: conception, design, analysis, interpretation, manuscript writing; David E. Wassef: design, analysis, interpretation, manuscript writing; Paul T. Cowan: design, analysis, interpretation, manuscript writing; Richard Chan Woo Park: design, analysis, interpretation, manuscript writing; Andrey Filimonov: design, analysis, interpretation, manuscript writing, final approval;

Funding

None.

Declarations

Level of Evidence

4.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Jung C, Padman R, Anwar S (2019) The impact of medicare part D prescription drug benefit program on generic drug prescription. Med (Baltim) 98(32):e16646. 10.1097/MD.0000000000016646 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Collet DA, Urban MB, Amin A (2024) Potential medicare part D savings on ophthalmic generic drugs. JAMA Ophthalmol 142(7):678–680. 10.1001/jamaophthalmol.2024.1717 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cortese BD, Chang SS, Talwar R (2023) Urological drug price stewardship: potential cost savings based on the mark Cuban cost plus drug company model. J Urol Published Online Febr. 10.1097/JU.0000000000003083 [DOI] [PubMed] [Google Scholar]
  • 4.Cortese BD, Dusetzina SB, Luckenbaugh AN et al (2023) Projected savings for generic oncology drugs purchased via mark Cuban cost plus drug company versus in medicare. J Clin Oncol 41(29):4664–4668. 10.1200/JCO.23.00079 [DOI] [PubMed] [Google Scholar]
  • 5.Rha J, Rathi VK, Naunheim MR, Miller LE, Gadkaree SK, Gray ST (2021) Markup on services provided to medicare beneficiaries by otolaryngologists in 2017: implications for surprise billing. Otolaryngol Neck Surg 165(5):662–666. 10.1177/0194599821994826 [DOI] [PubMed] [Google Scholar]
  • 6.Berkowitz ST, Groth S, Sternberg P, Patel S (2024) Drug savings for medicare part D beneficiaries using a Direct-to-Consumer model. Ophthalmology 131(4):509–510. 10.1016/j.ophtha.2023.12.004 [DOI] [PubMed] [Google Scholar]
  • 7.Lalani HS, Tessema FA, Kesselheim AS, Rome BN (2024) Availability and cost of expensive and common generic prescription drugs: A Cross-sectional analysis of Direct-to-Consumer pharmacies. J Gen Intern Med 39(12):2187–2195. 10.1007/s11606-024-08623-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Feldman WB, Rome BN, Raimond VC, Gagne JJ, Kesselheim AS (2021) Estimating rebates and other discounts received by medicare part D. JAMA Health Forum 2(6):e210626. 10.1001/jamahealthforum.2021.0626 [DOI] [PubMed] [Google Scholar]
  • 9.Trish E, Gascue L, Ribero R, Van Nuys K, Joyce G (2021) Comparison of spending on common generic drugs by medicare vs Costco members. JAMA Intern Med 181(10):1414–1416. 10.1001/jamainternmed.2021.3366 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Indian Journal of Otolaryngology and Head & Neck Surgery are provided here courtesy of Springer

RESOURCES